ML20245J544
ML20245J544 | |
Person / Time | |
---|---|
Site: | Seabrook |
Issue date: | 06/26/1989 |
From: | Backus R BACKUS, MEYER & SOLOMON, SEACOAST ANTI-POLLUTION LEAGUE |
To: | |
References | |
CON-#389-8832 OL, NUDOCS 8907030085 | |
Download: ML20245J544 (25) | |
Text
{{#Wiki_filter:_ __-_-_-_-- , 5
%L LELATEo cortncseonuqqq w yETEn .m u 89 Juil 29 P4 :05 UNITED STATES OF AMERICA T, NUCLEAR REGULATORY COMM1SSION ' j ATOMIC SAFETY AND LICENSING BOARD Before the Administrative Judges:
Ivan W. Smith, Chairman Dr. Richard F. Cole Kenneth A. McCollom
)
In the Matter of )
)
Docke t Nos. 50-443-OL [fdb PUBLIC SERVICE COMPANY ) (Off-Site EP) 0F NEW HAMPSHIRE, ET AL. )
)
(Seabrook Station, Unit 1) ) June 26, 1989 _) SURREBUTTAL TESTIMONY OF BELTON A. BURROWS, MD ON ISSUES RE: MS-1 HOSPITALS, RECEPTION / DECONTAMINATION CENTERS AND FEMA (GM) MS-1 GUIDANCE Seacoas t Anti-Pollution League By its attorney, BACKUS, MEYER & SOLOMON 116 Lowell Street ! P.O. Box 516 Manchester, N.H. 03105
;;a7Mn88ob T $03
- 1. Q. Would you please state your name, current positions and relevant experience?
A. My name is Belton A. Burrows, MD. I am currently Chief of Nuclear Medicine at the Boston VA Hospital and Research Professor of Medicine at Boston University School of Medicine. I have worked with both research and clinical applications of radionuclides for 40 years. I
- 2. Q. Have you reviewed materials related to the radiological emergency response plans for Seabrook Station?
A. Yes, I have. I have reviewed sections of the Seabrook Plan for Massachuse tts Communities (SPMC) related to Reception / Decontamination Centers, SPMC Implementing Procedure 2.9 " Radiological Moni toring/Decontamina tion" , SPMC Implementing Procedure 3.4 l
" Monitoring Trailer Activation and Deactivation", and FEMA Guidance Memorandum (GM) MS-1, Medical Services, dated November 13, 1986. I have also reviewed pages 52-64 of the Applicants' Rebuttal Testimony No. 6 (Protective Actions for Particular Populations) and Applicants' Rebuttal Testimony No.17 (Radiological Monitoring Process).
- 3. Q. Taking up first the subject of the FEMA Guidance Memorandum (GM) MS-1 Medical Services, do you agree with che statement that Joint Commission on Accreditation of Hospitals (JCAH) accreditation suffices to assure that medical f acilities have adequate technical information, professional support and treatment capabilities for handling
" contaminated injured" individuals? !
l A. No. JCAH accreditation in and of itself does not suffice to provide l I assurance that a hospital will be prepared to offer such services. The i t l
- _ _ - _ _ _ _ _ _ _ _ - _ _ _ ~
l
I _3_ reason for that is that a hospital can obtain JCAH accreditation even if it does not have its own Nuclear Medicine Service as long as that hospital has an agreement with another hospital that does have a Nuclear Medicine Service which is accredited to provide such services.
- 4. Q. Is having one physician' and one nurse on call within about 2 hours at both an MS-1 hospital and back-up hospital, who can supervise the evaluation and treatment of radiologically " contaminated injured" members of the general public, a strict enough planning requirement for '
assuring medical treatment preparedness for nuclear plant accidents? A. No. I do not think it is sufficient. I believe that that is a level of preparedness that does not approach what is reasonably attainable. Further, I think that the expertise of the medical staff needa more definition.
- 5. Q. Does the fact that a physician is a board certified radiologist qualify him or her to supervise a hospital response to a radiological emergency? l A. That cannot necessarily be assumed. '
It could be that a particular individual with such certification might be sufficiently knowledgeable, but the title " board certified radiologist" does not assure that the person holding such title is equipped with specific enough knowledge of ! radiobiology and radionuclides for handling radiological emergencies.
- 6. Q. Do you believe that Lao MS-1 hospitals provide a sufficient level of planning on the Massachusetts side of the border for a site like the Seabrook site?
A. No. Even if only 10% of the estimated number of evacuees were referred i _____ __ ____ _ ____ _ _ ___________________________________J
1
, I \
l 1
]
l I from the Reception Centers to the two designated MS-1 hospitals, it would overtax those facilities as they are described in the Applicants' l I testimony. From the population estimates it is clear that two j l hospitals would not be sufficient. The FEMA document (GM) MS-1 does not provide sufficient guidelines f or the number and capabilities of hospitals. Simply requiring an j agreement with two hospitals does not alone provide a meaningful planning standard. , ( l
- 7. Q. Moving on to the issues regarding the Reception / Decontamination Centers, do you have specific concerns about them? i 1
A. I am concerned that the (>1an does not have trained medical personnel i there to make referrals for further treatment when needed. I believe ' that each individual who has suspected contamination needs medical follow-up services since one cannot rule out the possibility of significant body burdens with only a surface scan. The surface scan serves the important function of indicating that an individual hrs been i 1 exposed to excess environmental radioactivity, but further checking of an individual is called for if there has been a contaminating release. I I
- 8. Q. Does the Applicants' plan to register the evacuees at the Reception / Decontamination Centers for inclusion in a tracking program ,
alleviate your concerns in that regard? A. No. It does not, it will require medical judgment based upon sufficient information to determine whether or not there is the necessity for immediate medical referral for individual evacuees. The possibility of internal body burdens must be addressed.
I *
. 1 1
1
- 9. Q. What could be done to improve the Reception / Decontamination Centers to address the concerns you have raised?
A. Each Reception / Decontamination Center should have a portable pulse j height analyzer with a sensitive sodium iodide detector so that the radionuclides making up the contamination can be identified and l treatment planned accordingly. Using spectral analysis, one can l determine which radionuclides are making up the contaminants' l I
" fingerprints". If chelation or other therapies are advisable given the I results of the analysis, they should be instituted within as little as I
an hour or so. 1
- 10. Q. Weuld you expect body burdens in a radiological emergency where !
I contaminants escape from the plant in a plume?
]
l A. Yes, I would. Even ruling out the ingestion of contaminated water and . ! 1 1 focdstuffs, one would still expect internal body burdens due to l inhalation and skin absorption.
- 11. Q. What if only noble gases were released in an accident? Would that not relieve your concerns about internal body burdens?
A. No. Certain of the decay products of noble gases can pose a biological hazard. Certain radionuclides of Xenon, for example, decay to Cesium, an element which is a biological analogue of potassium. Cesium 137, with a 30 year half-life, constitutes 18% of the long-lived fission products and because of its biological and physical properties may present a radiation hazard significantly greater than conventional dosime try would sugges t.
- 12. Q. Putting aside your concern about internal body burdens, do you believe that the Reception / Decontamination Centers as they are presently set up under the plan could monitor approximately 8300 evacuees in a 12 hour time frame even if 4 more monitoring stations were added?
A. Based on my experience, I cannot imagine how the logistical problems presented by an unselected mixed population of this size arriving at one of the Decontamination f acilities described in the Applicants' testimony could be dealt with in this kind of a time frame. It seems highly unlikely that such a large group could be successfully monitored within 12 hours in the facilities described by the Applicants in their plan and testimony.
- 13. Q. Does that conclude your tes timony?
A. Yes, it does. 1 l I
i CURRICULUM VITAE Name: Belton Allyn Burrows Born: March 3, 1918 Married: Dorinda McKenzie Burrows Children: Six Address: 50 Edgehill Road, Brookline, Mass. 02146 Degrees: A. B. Yale, 1939; M.D. Columbia, 1943 Membership in Scientific and Professional Organizations: ' American Association of University Professors American Board of Internal Medicine American Clinical and Climatological Association American College of Physicians American Federation for Clinical Research American Society for Clinical Investigation American Society of Nephrology American Thyroid Association Endocrine Society Massachusetts Medical Society New York Academy of Science Norfolk District Medical Society Society of Nuclear Medicine American Board of Nuclear Medicine Hospital Appointments: Intern, New Haven Hospital, July 1943 - April 1944 Asst. Resident in Medicine, New Haven Hospital, July 1946 - June 1947 Asst. Resident, Evans Memorial - July 1947 - June 1948 Life Insurance Medical Research Fund Fellow, Evans Memorial, July 1948 - June 1950 Asst. in Medicine, Boston City Hospital, August 1948 - ' Assoc. Visiting Physician, University Hospital (Mass. Memorial) June 1950 - . Member, Evans, Memorial, June 1950 - , Senior Physician, Radioisotope Unit, Cushing VA Hospital Framingham, Mass. , June 1950 - Sept. 1952 Senior Physician, Radioisotope Unit, Boston VA Hospital October 1952 - November 1953 Chief, Radioisotope Service, Boston VA Hospital November 1953 - Acting Director, Nuclear Medicine Service, Veterans Administration Central Office, Sept. 1967 - 1973
Curriculum Vitae B.A. Burrows, M.D.- i i Military Service: . . 1st' Lieutenant - April 1944 : June 1945 i Captain - July 1945 - June 1946,;Finney General Hospital; [ Thomasville, Georgia; Hoff General ~ Hospital, j Santa Barbara, California; ' 252nd General Hospital; r 1st General Hospital; 126 lst Engineer Combat [ Battalion; 1173 Engineer' Combat Group; Post ;- Surgeon, Engineer School, European Theatre.- j 6 Academic Appointments: -{ Asst..in Medicine, Yale Medical School July 1943 - April 1944-
' Asst. in Medicine, Yale Medical School July.1946 - June.1947 . .
Asst. in Medicine, Boston University School of Medicine -[ July 1947 - February 1950 . t Instructor in Medicine, Boston University School of Medicine - '~ February 1950 - June 1950' : Asst. Professor of Medicine, Boston University School of .,_ Medicine, June 1950 - June 1957
. Assoc. Professor of Medicine,- Boston University School i*
of Medicine, June 1957 - June 196S Research Professor of Medicine, Boston University School i of Medicine, July 1965 - ! Consultant, Lemuel'Shattuck Hospital, Jamaica. Plain, Mass. June 1955 - [. Consultant, Framingham Union Hospital, Framingham, Mass. l l 1960 - i 1 Other: Member, Scientific Advisory Committee, New England Primate Center,- 1965 - 1973. , Member, Scientific Medical Founda' tion, Boston, 1966 - 1973 -
!'j Trustee, . Society of Nuclear Medicine, 1964 - 1972 ,
Editor, Journal'of Nuclear Medicine, June, 1970 -:1975 I
, Consultgnt, Nu, clear Reguletory Commiss' ion, 1977 -
S 4 I l j i i 1 I 1
. i \ %' ,~ b . i j
.6 l Bibliography - Belton A. Burrows, M.D. ! June 1974
- 1. Grossman, C.M., Sappington, T.S., Burrows, B.A., Lavietes, P.H.
and Peters, J.P. Nitrogen metabolism in acute infections. J. Clin. Invest. 24:523-531, July 1945.
- 2. Danowski, T.S., Elkinton, J.R., Burrows, B.A. and'Winkler, A.W. j Exchanges of sodium and potassium in familia 1' periodic paralysis. 1 lJ. Clin. Invest. 27 :65-74, January 1948. j
)
- 3. Burnett,- C.H. , . Burrows, B. A. and Commons, R.R. ~ Kidney function in osteomalacia resulting from renal acidosis. J. Clin.. Invest. 27:
~~
527, July 1948. i
- 4. Burnett, C.H. and Burrows, B. A. Repair solutions.in.the treatment of acidosis and alkalosis. - Med. Clin. N. A. pp.1293-1307, Sept.1948.
- 5. Burnett, C.H. , Burrows, B. A. and Commons, R.R. The lack of corelation between glomerular filtration rate, and serum electrolyte concentration changes, urinary electrolyte excretion or' edema formation,. following sodium loads in subjects with normal kidneys, glomerulonephritis, and the nephrotic syndrome. J. Clin. Invest. 28:773, July 1949..
- 6. Emerson, C.P. , Jr. and Burrows, B. A. The mechanism of anemia and its influence on renal function in chronic uremia. J. Clin. Invest.
28:6, 8 779, July 1949.
- 7. Wilkins, R.W., Culbertson, J.W., Burrows, B.A., Tinsley, C.M.,
Judson, W.E., and Burnett, C.H. Antidiuresis and renal vasoconstriction-following venous congestion of the limbs in normal hypertensive and splanchnicectomized subjects. J. Clin. Invest. 28:819, 1949.
- 8. Burrows, B. A. , Commons, R.R. and Burnett, C.H. Sodium and potassium excretion in patients with renal insufficiency, Am. J. Med.
7:423, 1949.
, '9. Burnett, C.H. , Burrows, B. A. and Commons, R.R. ' Studies of alkalosis.- -I. Senal function during and following. alkalosis resulting from pyloric-obstruction. J. Clin. Invest. 19:169,1950.
- 10. Burnett, C.H. , Burrows, B. A. , Commons, R.R. and Towery, B.T.
Studies of alkalosis. II. Electrolyte abnormalities in alkalosis resulting from pyloric obstruction. J. Clin. Invest. 2j[:175, 1950. 11 ~. McP.ay, D.G., Burnett, G.H. and. Burrows, B.A. Panhypopituitarism: Case report correlating clinical and pathologic findings. J. Clin. Endocrin. 10,:540, 1950.
- 12. Burrows, B.A. and Sisson, J.H. The measurement of total body potassium by the radioisotope dilution technique. J. Clin. Invest.- 29:801-802, 1950.
l _ ._____.______m_m.._ _ _ _ _
Bibliography - B.A. Burrows, M.D. Page 2, June 1974
- 13. Judson, W.E., Epstein, F.J., Tinsely, C.M., Burrows, B.A. and Wilkins, R.W. The hemodynamic and renal functional effects of venous l
congestion of the limbs in patients with. diabetes insipidus. J. Clin. Invest. 29:826-827, 1950.
- 14. Ingbar, S.H. , ReIman, A.S. , Burrows, B. A. , Kass , E.H. , Sisson, J.H.
and Burnett, C.H. Changes in normal renal function resulting from ACTH and cortisone. J. Clin. Invest. 19:824,1950.
- 15. Burnett, C.H. , Greer, M. A.', Burrows , B. A. , Sisson, J.H. , Relman, A. S. , ,
Weinstein, L. A. , and Colburne, C.G. The effects of cortisone on the course of acute glomerulonephritis. N.E.J. Med. 243:1028-1032, 1950.
- 16. Ingbar, S.H. , Kass, E.H. , Burnett, C.H., Relman, A.S., Burrows, B.A.
and Sisson, J.H. The effects of ACTH and cortisone on the renal tubular transport of uric acid, phosphorus, and electrolytes in patients with normal renal and adrenal function. J. Lab. Clin. Med. 38,:533-541, 1951.
- 17. Burnett, C.H. , Relman, A.S. , Burrows , B. A. , Sisson, J.H. and Ingbar, S.H.
Renal excretion of hypertonic sodium solutions in Addison's Disease with observations on the effects of cortisone. Am. J. Med. 11,:238-239, 1951.
- 18. Ingbar, S.H. , Kas s , E.H. , Burnett, C.H., Relman, A.S., Burrows, B.A. and Sisson, J.H.
l ' The effects of ACTH and cortisone on the renal tubular transport of uric acid, phosphorus, electrolytes in patients with normal renal and adrenal function. Proc. Second Clin. ACTH Conf., pp. 130-133, 1951.
- 19. Burrows, B.A. and Ross, J.F. The management of hyperthyroidism. Med.
Clin. N.A., pp. 1305-1321, Sept. 1951.
- 20. Burrows, B.A., Ashley, M.M. and Sisson, J.H. Radioactive potassium distribution in metabolic disorders. J. Clin. Invest. 31,:620, 1952.
- 21. 'Papper, S., Burrows, B.A., Ingbar, S.H., Sisson, J.H. and Ross, J.F. .
The effects of 1-thyroxine sodium on non-toxic goitre, on myxoedema, and on the thyroid upt.ake'of radioactive iodine. N.E.J. Med. 247:897-899, 1952. ;
- 22. Burrows, B.A., Dell, E.S., and Ross, J.F.
Radioactive iodine conversion ratio in thyroid diagnosis. Am. J. Med. 14:498, 1953.
- 23. Burrows, B. A. and Ross, J.F. The uptake of stable iodine compared with the serum protein-bound iodine concentration in normal subjects and patients with thyroid disease. J. Clin. Endocrin. 6 Metab.13:1358-1368, 1953.
- 24. Burrows, B.A. Iodine metabolism in thyroid diagnosis.
Boston Medical Quarterly 4_: November 3, 1953. v.
Bibliography - B.A. Burrows, M.D. I Page 3, June 1974
- 25. Burrows, B. A. , Dell, E. , Graham, D. and Ross , J.F. The radioiodine uptake and the protein-bound iodine in treated hyperthyroidism. Clin.
l Res. Proc. 1:20, 1953. i
- 26. Burrows, B.A., Denton, J., Ferguson, B. and Ross, J.F.
Changes in body potassium in hepatic decompensation. Clin. Res. Ploc. 1_:111, 1953,
- 27. Hine, G.J., Burrows, B.A. and Ross, J.F.
Performance of scintillation counters in measurement of Il31 uptake by the thyroid gland. Tracerlog 56:2, 1953. *
- 28. Burrows, B.A., Ashley, M.M. and Sisson, J.H. Exchangeable potassium content in metabolic disorders. Clin. Res. Proc. 1_,:31, 1953.
- 29. Burrows, B.A. The relationship of thyroid hormone utilization to its serum level. J. Clin. Invest. 32:558, 1953. a l
- 30. Burrows, B.A., Peters, T. and Ross, J.F. 1 The tissue utilization of l endogenous thyroid hormone in human subjects. J. Clin. Invest. 3,3:921, <
1954. '
- 31. Burrows, B.A., Hine, G.J. and Ross, J.F.
The simultaneous determination of radiosodium, radiopotassium and radiosulphate spaces. Clin. Res. Proc. 2_:81, 1954.
- 32. Hine, G.J. , Burrows, B. A. , Apt, L., Pollycover, M., Ross, J.F. and I Sarkes, L.A. Scintillation counting for multiple tracer studies. j Nucleonics 1,,3,:23, 3 1955, j
- 33. Hine , G.J. and Burrows , B. A. The application of scintillation counter spectroscopy to radioactive tracer techniques. Abstract, Proc. Int.
Conf, on the Peaceful Uses of Atomic Energy, Geneva, Switzerland, August, 1955. w )
- 34. Burrows, B. A. and Ross, J.F. The use of radiosodium and radioponssium tracer studies in man. Proc. Int. Conf. on the Peaceful Uses of Atomic Energy, Geneva, Switzerland, August, 1955. '
- 35. Hine, G.J., Burrows, B.A., Apt, L., Pollycove, M., Ross, J.F.'and Sarkes, L. A. Scintillation counting for multiple-tracer studies, Nucleonics 13/2, 23, 1955.
- 36. Burrows, B.A., Davis, D.J., Kelly, J.F.,
Lewis, A.A.G., Ross, J.F. The effects of surgical procedures on simultaneously determined radio-sodium, radiosulphate, and radiopotassium cpaces in ' human subjects. J. Clin. Invest. ,34,:924-925, 1955.
- 37. Mitchell, M. , Burrows, B. A. and Ross, J.F. The relationship between clinical and labo: atory findings in hyperthyroidism and the response to radioiodine theraly. Clin. Res. Proc. 3,:121, 1955.
t
Bibliography - B. A. Burrows, M.D. Page 4, June 1974
- 38. Peters, T., Burrows, B.A. and Lowell, F.C. Physical binding of insulin by gamma globulin from insulin-resistant subjects. Fed. Proc. 16,:608, 1956.
- 39. Hollander, W., Reilly, P., and Burrows, B.A. L subjects as indicated by the disappearance of I{gphatic flowalbumin labelled in human from the subcutaneous tissues. J. Clin. Invest. 35,:713, 1956.
- 40. Lambie, A.T., Roy, A.M., Relman, A.S., Burrows, B.A. and Schwartz, W.B.
On the mechanism of rubidium-induced acidosis. Clin. Res. Proc. 4,:128, 1956. .
- 41. Kunin, A.S., Roy, A.M.,
Dearbonn,
E.H., Burrows, B.A. and Relman, A.S. A comparison of the renal transport of rubidium and potassium. Clin. Res. Proc. 4,:136, 1956.
- 42. Relman, A.S., Lambie, A.T., Roy, A.M., and Burrows, B.A. The nature of cation accumulation of muscle cells: Displacement of potassium by rubidium and cesium. Clin. Res. Proc. 4,:150, 1956.
- 43. Mitchell, M.L., Burrows, B.A., Dell, E.S., Graham, D.E. The effect of thyroid stimulating hormone on the thyroidal iodine turnover. J. Clin.
Endocrinol. 6 Metab.16,:976, July 1956.
- 44. Hine, G.J. and Burrows, B. A. Plastic well scintillation counters for B- and y-ray measurements. Abstract, Radiation Res. 5,:482, 1956.
- 45. Hine, G.J., Burrows, B.A. and Ross, J.F. Thyroid uptake measurements.
Nucleonics 15/1:54, 1957.
- 46. Burrows, B. A. , Peters, T. , Lowell, F.C. , Trakas, A.N. and Reilly, P.
Physical binding of insulin by gamma globulins of insulin-resistant subjects. J. Clin. Invest. 36:393-397, 1957.
' 47. Lambie, A.T., Burrows, B.A. and Sommers,.S.C. Clinopathologic conference. -
Refractory anemia, agammaglobulinemia and mediastinal temor. Am. J. Clin. Path. 27:444-452, April 1957. -
- 48. Relman, A.S. , Lambie, A.T. , Burrows , B. A. , and Roy, A.M. Cation accumula-tion by muscle tissue; the displacement of potassium by rubidium and cesium in the living animal. J. Clin. Invest. 36:1249-1256, August 1957.
- 49. Burrows, B.A. Tracer studies in medical diagnosis. Med. Clin. N.A.
- p. 1181, Sept. 1957.
- 50. Hollander, W., Chobanian, C. and Burrows, B.A. Electrolyte and water metabolism essential, renal or steroid-induced hypertension. Circulation 15:893, Oct. 1957.
- 51. Chobanian, A. , Burrows, B. A. and Hollander, W. Electrolyte and water metabolism in early congestive heart failure. Circulation 15,:866, Oct. 1957.
t
. Bibliography - B.A. Burrows, M.D. -
Page 5, June 1974 ;
- 52. Englert, E., Ingelfinger, F.J. and Burrows, B. A. Duodenal collections:
Quantitative unreliability and a method of correction. Clin. Res. 6:32 January 1958. --
- 53. Block, J.B., Hine, G.J. and Burrows, B.A. The use of carrier Diodrast '
with Il31-Diodrast. Clin. Res. 6_:38, January 1958.
- 54. Chobanian, A., Burrows, B.A. and Ho11ander, W. I The relationship of blood j pressure to changes in body fluids and electrolytes in steroid hypertension, j Clin. Res. 6_:227, April, 1958. 1 l
- 55. Block, J.B. and Burrows, B.A. Renal clearance of 1131-Diodrast at low j plasma concentrations. Clin. Res. 6_:284, April, 1958. l
. k
- 56. Clifton, J. A. , Ingelfinger, F.J. and Burrows, B. A. The effect of j cortisone and hydrocortisone on hepatic excretory function. J. Lab. 6 j Clin. Med. 51:701-708, May 1958.
j i
- 57. Slingerland, D.W., Dell, E.S., Graham, D.E., Trakas, A.P. and Burrows, B.A.
Thyroid secretion of nonthyroxine iodine. J. Clin. Invest. 37:932, June 1958. l
- 58. Burrows, B.A. Goiter diagnosis and treatment. Med. Clin. N.A. pp.1291-1303, i Se'p t . 1958.
- 59. Block, J.B., Hine, G.J. and Burrows, B.A. The use of carrier.diodrast with 1131-Diodrast. Abstract, Clin. Res. 6_:38, 1958.
- 60. Hine, G.J. and Burrows, B.A. Total and partial body radioactivity measure-ments for metabolic tracer studies. Proc. Second United Nations Int.. Conf.
on Peaceful Uses of Atomic Energy, Vol. 26:213, 1958.
- 61. Hine, G.J. and Burrows, B.A. External body counting for radioisotope distribution studies. Abstract, Radiation Res. 9_:129, 1958.., l l
/ - -- 62. Jagger, P.I., Hine, G.J., Cardarelli, J.A. and Burrows, B.A. Effects of dietary sodium on " exchangeable" sodium. Abstract, Clin. Res. 7_:283, 1959.
- 63. Jagger, P.I., Block, J.B. an'd Burrows, B.A. Hepatic transport of 1131-'Diodras t.
Clin. Res. 7:34, January, 19591 1
- 64. Block J.B., Graham, D.E. and Burrows, B.A. The influenceof protein binding on Ilbl-Diodrast excretion. J. Clin. Invest. 3_6,:988, June, 1959. N
- 65. Hine, G.J., Jagger, P.I. and Burrows, B.A. External body counting for radio-isotope distribution studies. -Abstract, 9th Int. Congress Radiology, Munich, July 1959.
- 66. Block, J. B. , Burrows, B. A. Diagnostic use of I131-Diodrast in hypertension due to unilateral renal disease. Circulation 18,:696, October, 1959.
- 67. Hine, G.J. , Cardarelli, J. and Burrows, B. A. External body counting for radioisotope distribution studies. J. Lab. 6 Clin. Med. 5_5:476-485, 5 March 1960.
)
- Bibliography - B.A. Burrows, M.D. Page 6, June 1974
- 68. Jagger, P.I., Hine, G.J., Cardarelli, J.A. and Burrows, B.A. Sodium 22 equilibrium and exchangeable sodium determinations in edematous patients.
Clin. Res. 8,:229, April 1960.
- 69. Hine, G.J., Jagger, P.I., Burrows, B.A. and Cardarelli, J.A.
Measurement of body radioactivity for studies of sodium metabolism.
'J. Lab.' 6 Clin. Med. 5_5:476, 5 May 1960.
- 70. Burrows, B.A., Slingerland, D.W., Liuzzi, A., Dell, E.S. and Graham, D.E.
- Thyroidal iodide secretion. J. Clin. Invest. 39:975, June, 1960.
- 71. Block, J.B., Hine G.J. and Burrows, B.A. Effects of carrier Diodrast on excretion of'I I31 -labelled Diodrast. J. Lab. 6 Clin. Med. 56:110, -
July 1960.
- 72. Englert, E. , Jr. , Burrows , B. A. and Ingelfinger, F.J. ' Differential analysis of the stages of hepatic excretory function with gamma emitting isotopes; I. Methods and validation. J. Lab. 6 Clin. Med. 5,6_:181-192, August, 1960.
- 73. Englert, E. , Jr. , Burrows, B. A. and Ingelfinger, F.J. Differential analysis of the stages of hepatic excretory function with gamma emitting isotopes; II. Clinical results. J. Lab. 6 Clin. Med. 56:193, August, 1960.
- 74. Block, J.B. and Burrows, B.A. Influence of serum protein binding on renal clearance of Il31-Labelled Diodrast. J. Lab. 6 Clin. Med. 56:463, Sept. 1960.
Block, J.B., Hine, G.J. and Burrows, B.A. 131 -Diodrast studies in unilateral
- 75. 1 renal disease. Circulation 22,:913, November 1960.
- 76. Hollander, W., B.A. Lymphatic flow in human subjects as indicated by Reilly, P. and Burrows,131-labelled the disappearance of 1 albumin from the subcutaneous tissues. J. Clin. Invest. Feb. 1961.
- t l
- 77. Hollander, W., Chobanian, A.V., and Burrows, B.A. Body fluid and electrolyte composition in arterial hypertension. 1. ' Studies in essential, renal and malignant hypertension. J. Clin. Invest. 4_0,:408-415, Feb. 1961. . ,
i
. i
- 78. Chobanian, A.V., Burrows, B.A. and Hollander, W. Body fluid and electrolyte i composition in arterial hypertiinsion. II. Studies in mineral-corticoid hypertension. J. Clin. Invest. Q:416-422, Feb. 1961.
i
- 79. Farmelant, M.H. and Burrows, B.A. Urine flow response to mannitol loading j in unilateral renal disease. J. Clin. Invest. 40,:1037, June 1961. j i
- 80. Chobanian, A.V. , Burrows , B. A. and Hollander, W. Body fluid and electrolyte !
composition in cardiac patients with severe heart disease but without peripheral edema. Circulation 24:748-753, 1961. ! l
- 81. Fordtran, J.S., Levitan, R., Bickerman, V. and Burrows, B.A. Kinetics of water i absorption in the human intestine. Trans. Assoc. Amer. Phycns. _7,4: 4 1961.
l
n ,,' 4 Bibliography - B. A. Burrows, M.D. Page 7, ' June 1974
- 82. Hine, G.J. , Jagger, P. I. and Burrows, B. A. Use of clinical body counter for long-term exchangeable sodium studies, "Whole-Body Counting". Int. Atomic Energy Agency, Vienna, P. 413-426, 1962.
I
- 83. Hine, G.J., Farmelant, M.H., Burrows, B.A. and Cardarelli, J.A. Four-channel magnetic tape recording and digital integration analysis of radiohippuran renal function tests. J. Nuclear Med. 3,:219, 1962 (Abstr.)
- 84. Chobanian, A.V., Burrows, B.A., Hollander, W. Body cholesterol . metabolism '
in man. II. Measurement _ of body cholesterol miscible pool and turnover rate. i J. Clin. Invest. 41,:1783, 1962. ,
- 85. Levitan, R. , Fordtran, J.S. , Burrows, B. A. and Ingelfinger, F.J. Wa'ter and salt absorption in the human colon. J. Clin. Invest. ;[L:1754, 1962.
- 86. Slingerland, D.W. and Burrows, B. A. Inhibition by propylthiouracil of the. '
peripheral metabolism of radiothyroxine. J. Clin. Endocrinol. 6 Metab. 22; 511, 1962. ! i l
- 87. Slingerland, D.W. and Burrows, B.A. A probable abnormality in interthyroidal ]
iodine metabolism in hyperthyroidism. J. Clin. Endocrinol. 6 Metab. 22:368, j 1962. i l
- 88. Hine, G.J., Farmelant, M.H., Cardarelli, J.A., and Burrows, B.A. Four channel f magnetic tape recording and digital analysis of radio-hippuran renal function tests in normal subjects. J. Nuclear Med. 4;371, 1963.
1
- 89. Burrows, B.A. Aldosterone, in The Practioner 190:272, 1963. I 1
- 90. Jagger, P. I. , Hine, G.J. , Cardarelli, J. A. and Burrows, B. A. Influence of .
sodium intake on exchangeable sodium in normal human subjects. J. Clin. Invest, g:1459, 1963.
- 91. Farmelant, M.H. , Lipetz , C. A. , Bikerman, V. , and Burrows, B. A. Radioisotopic l renal function studies and surgical findings in 102 hypertensive. patients.
Am. J. Surg. 107:50, 1964. ,
- 92. Farmelant, M.H., Sachs, C., Genna, S. and Burrows, B.A. Physiological basis of radioisotopic renal function studies. Clin. Res. 12,:251, 1964. ,
- 93. Farmelant, M.H. , Sachs, C.E. , Hine, G.J. and Burrows, B. A. Use of radio-isotopic renal function studies to select patients for surgery in renal arterial stenosis. J. Clin.. Invest. 43,:1308, 1964.
- 94. Tyson, I., Bickerman, V., and' Burrows, B.A. Potassium deficit in hyper-tensive patients. Clin. Res. 12,198, 1964. ;
- 95. Genna, S. , Dukstein, W. , Jones, R. and Burrows, B. A. Whole body counting of non-uniformly distributed radioisotopes. J. Nuclear Med. 5,:364, 1964. ;
1
Bibliography - B.A. Burrows, M.D. , Page 8, June 1974
- 96. Cardarelli, J.A., Mulvey, P.F., Jr., Murphy, C., Cooper, R., and Burrows, B.A. ,
Sensitivity of Bremsstrahlung activation analysis for iodine determination. J. Nucicar Med. 6_:344, 1965.
- 97. Farmela g M.H., Dukstein, W.G. and Burrows, B.A. An effect of mannitol on renal I -hippuran excretion independent of urine flow rate. J. Clin. Invest.
4_4:1045, 4 1965. .
- 98. Burrows, B.A., Tyson, I., Dukstein, W.G. and Genna, '. Clinical measurements of body radioactivity. Transactions of the American Clinical and Climatological Association, Vol. E:25, 1965. ;
- 99. Hine, Gerald J., Genna, Sebastian and Burrows, B.A. Geometrical and attenua-tion corrections for a two crystal whole body counter: Body scanning with an 8 x 4 in. NaI crystal. Radioactivity in Man, G.V. Meneely, Ed., C.C. Thomas, !
Springfield, Ill., p. 135, 1965. 100. Burrows, B.A. and Farmelant, M.H. The use of radioactive isotopes in the diagnosis of hypertension. Progress in Cardiovascular Disease, 8_:159-169, 1965. 101. Burrows, B.A., Mulvey, P.F., Jr., Cardarelli, J.A. and Cooper, R. Bremsstrah-lung Activation Analysis of Iodine and Mercury. Radioactive Isotope in Klinik und Forschung, 7:365, 1967. 102. Burrows, B.A., Farmelant, M.H., Ingelfinger, F.J., Relman, A.S., and Finland, M. Controversies in Internal Medicine, W.B. Saunders, Philadelphia, p. 379, 1966. 103. Mulvey, P. , Cardarelli, J. A. , Zoukis, M. , Cooper, R.D. and Burrows, B. A. Sensitivity of Bremsstrahlung activation analysis for iodine determination. J. Nuclear Med. _7,:603, 1966. 104. Burrows, B.A. (Critical Review) From Radiation Lab to Clinic. Medical Opinion and Review, 1:40, 1966. 105. Tyson, B. h , Genna, S. , Jones , R. L. , Bikerman, V. , ' Graham, R. , and.-B'urrows , B. A. Electrolyte studies.with a total body counter.
- Physics in'Mediene and -
Biology 11,:168, 1 1966. 106. Tyson, I., Genna, S., Jones, R.,L., Bikerman, V. and Burrows, B.A. Studies of potassium depletion using measurements of total body potassium and body fluid compartments. J. Clin. Invest. 4_5,:1081,5 1966. 107. Farmelant, M.H. , Bakos, C. and Burrows, B. A. Evaluation of nephron disparity in the dog and the influence of hypotension and osmotic loads. J. Clin. Invest. 46:1954, 1967. 108. Farmelant, M.H. , Genna, S. , Sachs, C. and Burrows , B. A. Physiological verifica-tion of a model for interpretation of the renogram. J. Nucl. Med. 9_:314, 1968. ! 109. Genna, S. and Burrows, B.A. Design and performance of " constant-resolution" focussing collimator. J. Nucl. Med. 9_:318, 1968.
1
\ . i Bibliography - B.A. Burrows, M.D. I I , Page 9, June 1974 ,
110. Farmelant, M.H., Bakos, C. and Burrows, B.A. Response of renal transit time to variations of renal blood flow and solute excretion. J. Clin. l ; Invest. 47:328, 1968. ' 111. Farmelant, M.H., Sachs, C.E., Genna, S. and Burrows, B.A. A physiological . j model for renal excretion of labelled compounds. J. Nucl. Med. 10_:664, 1969. I 112. Farmelant, M.H. , Bakos, K. and Burrows, B. A. Physiological determinants of renal tubular passage times. J. Nucl. Med. 1_0:641, 0 1969. , 113. Farmelant, M.H., Sachs, C.E. and Burrows, B.A. The influence of tissue . '. I background radioactivity on the apparent role of renal accumulation of l ! radioactive compounds. J. Nucl. Med. 11:112, 1970. , i 114. Farmelant, M.H. and Burrows, B.A. Prognostic values of radioisotopic renal f function studies for prediction of cure in renovascular hypertension. J. Nucl. Med. 11_:743, 1 1970. l j 115. Tyson, B.I., Genna, S., Jones, R.L., Bikerman, V. and Burrows, B.A. l l Body potassium measurements with a total body counter. J. Nucl. Med. 1,1_: 255-259, 1970. 116. Tyson, B.I., Genna, S., Jones, R.L., Bikerman, V. and Burrows, B.A. Studies of potassium depletion using direct measurements of toth1 body potassium. J. Nucl. Med. 11:426, 1970. i i 117. Genna, S., Teager, H.M., Hunkar, D.B. and Burrows, B.A. Computer automated scintiscanning system. Phs. Med. Biol. 1_5_:214, 1970. 2 Genna, S., Farmelant, M.H. and Burrows, B.A. Improved scintiscan resolution 118. without sensitivity loss; " Constant-resolution" collimator. Medical Radio-
, isotope Scintigraphy. IAEA, Vienna, 561-574, 1969.
119. Farmelant, M.H., Dukstein, W., and Burrows', B.A. ' Influence of water cnd
- mannitol loads -on radiohippuran renal function curves. J. Nucl. Med. 1_1,:
. 186, 1970.
N ! 120. Cardarelli, J.A., Podolsky,"S. and Burrows, B.A. Neutron activatiqn analysis of nonradioactive iodinated insulin. J. Nuclear Medicine 12,:422, 1971. 121. Podolsky, S., Zimmerman, H.J., and Burrows, B.A. Decreased growth hormone and insulin response in normokalemic cirrhosis with potassium depletion. J. Nucl. Med. 12_:386, 1971. 122. Genna, S., Te.ager, H., Shore, H.H., and Burrows, B.A. Application of multi-window spectral analysis to dual radionuclides scintiscanning. J. Nucl. Med. 13_:431, 1972. ; 5 123. Genna, S., Teager, H., Shore, H.H., Zimmerman, S., Pang, S.C. and Burrows, , B.A. Four-view scintiscanning; image structuring through multi-window pulse height analysis. I.A.E.A. Symposium on Medical Radioisotope Scinti-graphy, Vienna, Austria, 1973, pp.133-154. _ m ..-__.____.__ s
, -Bibliography - B. A. Burrows, M.D.
Page 10, June 1974 124. Podolsky, S. , Zimmerman, H.J. , Burrows, B. A. , Cardarelli, J. A. and Pattavina, C.G.: Potassium depletion in hepatic cirrhosis: A re-versible cause of impaired growth hormone and insulin response to stimulation. New Eng J. Med. 288:644, 1973. 125. Slingerland, D. Ward, Hershman, Jerome M. , Dell, Elisabeth S. and Burrows, Belton A. Thyrotropin and PBI in radioiodine-treated hyperthyroid patients. The J. Clin. Endocrin. 6 Metab. 35,: No. 6, pp.912-917, Dec. 1972. 126. Slingerland, D.W. , Dell, E.S. , and Burrows, B. A. The spectrum of thyroid function after radioiodine treatment. Further advances in thyroid resea' ch. r Editors: K.FJ11inger and R. Hofer, Publ. Verlag der Wiener Medizinischen Akademie, 1971. 127. Farmelant,M.H. , Genna, S. , Burrows, B. A. Renal function studies with a scintillation camera, in Medical Radioisotope Scintigraphy, Vol. 2, Vienna, International Atomic Energy Agency,1969, pp. 229-240. 128. Burrows, B.A. and Podolsky, S. Studies of Potassium depletion in hepatic cirrhosis .using a whole body counter program. Annual Meeting of European Society of Nuclear Medicine, Athens, Greece, Sept. 1973. 129. Farmelant, M.H. , and Burrows, B. A. The Renogram: Physiologic basis and current clinical use. Seminars in Nuclear Medicine 4,:61-73, 1974, 130. Cardarelli, J. A. , Podolsky, S. and Burrows, B. A. Analysis of stable iodinated insulin by neutron-activation techniques. Int. J. of Applied Radiation and Isotopes,1970, Vol. 21, pp.513-517. 131. Podolsky, S. , Burrows, B A. , Zimmerman, H.J. an. Pattavina, C.G. Effect of chronic potassium depletion on growth hormone release in man. Excerpta Medica International Congress Series No. 244. Proceedings of the Second International Symposium, Milan, Italy, May 5-7, 1971. 132. Genna, S. , Pang, S. , 'Zimmerman, S. , Burrows, B. Dual Window Spatial Filtering. J. Nucl. Med. 15,:493, 1974. ~~ 135. McNeil, B.J. , Varady, P.D. , Burrows , B. A. and Adelstein, S.J. Cost / Benefit analysis in renovascular disease. J. Nucl. Med. 15:516, 1974. 134. Podolsky, S. and Burrows, B.A. Clinical applications of whole body counting to determine body potassium,in cirrhosis and diabetes mellitus. First World Congress of Nuclear Medicine, Tokyo, Japan, Sept. 1974. 135. Burrows, B.A., Cardarelli, J.A., Slingerland, D.W., Pattavina, C.G., Dell, E.S. Electrolyte Patterns in Acute Heart Failure. Annual Meeting of the Gesellshaft l Fur Nuclearmedizin, Munich, Germany, Sept. 1974. R_________ _
i
. .. 1 . 1 bibliography - B.A. Burrows, M.D.
Page 11, June 1976 1 i 136. Podolsky, S. and Burrows, B.A. Development of impaired glucose tolerance and insulin and growth hormone secretion with hepatic decompensation and , decreased body potassium. Clin. Res. 21_:_ 980, 1973. j 137. Slingerland, D.W., Sullivan, J., Dell, E., and Burrows, B.A. Effects of TRH in hyperthyroid patients treated with antithyroid drugs. Excerpta I Medica 361: 78,1975 (Abstr.) l I 138. Slingerland, D. Ward, Sullivan, J.J. , Dell, E.E. , Burrows , B.A. Thyroid Suppression Tests During Drug Treatment of Hyperthyroidism. Clinical Endo. 5:415-418, 1976. . 139. Genna, S., Pang, S.C., and Burrows, B.A. Application of fan reconstruction geometries to transmission and emission systems. (In) TerPogossian MM, Phelps.ME, Brownell GL, ed. Workshop on Reconstruction Tomography in Diagnostic Radiology and Nuclear Medicine, San Juan, Puerto Rico,17-19 Apr. 1975, New York, University Park Press (to be published). 140. Burrows, B.A. and Slingerland D.W. Prolonged Drug Treatment of Hyper-thyroidism. Clin. Res. 24: No. 3, April 1976. 141. McNeil, B.J. , Varady , P.D. , Burrows , B. A. , e t al. Measures of clinical efficacy. Cost effectiveness calculations in the diagnosit and treatment of hypertensive renalvascular disease. N.E.J.M. 293:216-221, 1975. 142. Genna, S. and Burrows, B.A. Analysis of an Arcuate Gamma Camera Design for Transaxial Reconstruction. Proc. IAEA Meeting on Medical Radionuclides Imaging, Los Angeles, Calif., October 25-29, 1976. 143. Burrows, B.A. and Slingerland, D.W. Prolonged Drug Treatment of Hyperthyroidism. Am. Clin. & Climatological Assoc. Meeting, Ponte Verda Beach, Florida, October 24,-27, 1976. 144. Burrows, Belton A, and Slingerland, D. Ward Prolonged Drug Treatment of ' l Hyperthyroidism. Transactions of the American Clinicsl & Climatological l Association, Vol. 88, pg. 219--226,1976. I 145. Podolsky, S. , Melissinos", C. and Burrows , B. A. Potassium deplettion in fatal diabetic ketoacidosis: High serum potassium with low body potassium and similar skeletal muscle and myocardial potassium values. Diabetes 23:381 (Suppl 1) 1974. 146. Podolsky, S. and Burrows, B.A. Comparison of "L-Sparing" and K-Losing" diuretic Regimens in Antihypertensive Therapy. Clin. Res. 25:508A, 1977 (Abstr.) 147. Burrows , B. A. and Podolsky, S. , Burney, S.W. , Cardarelli, J. A. and Genna, S. t ' Effects of Long-term Antihypertensive Diuretic Therapy on Serum and Body ' Potassium. Clin. Res. 23:525A,1977 (Abstr.) 148. Burrows , B. A. , Podolsky, S. , Burney, S.W. , Morley, D.P. , Cardarelli, J. A. , and Genna, S. Body Potassium Changes with Antihypertensive Diuretic Therapy. J. of duel. Med. 19: 721, 1978 (Abstr.) T-
, Bibliography - B.A. Burrows, M.D.
Page 12
- 149. Podolsky, S., Burrows, B.A. Development of Impaired Glucose Tolerance and Decreased Insulin and Crowth Hormone Secretion with Hepatic Decompensation and Reduced Body Potassium. Diabetes 26:411, 1977 (Abstr.)
150. Genna, S., Pang, S.C., Burrows, B.A. Analysis of an Arcuate Gamma Camera Design for Transaxial Reconstruction. Medical Radionuclides Imaging, Vol. 1, pg. 323-339, IAEA, Vienna, 1977. 151. Genna, S., Pang, S.C. and Burrows, B.A. Application of fan reconstruction geometries to transmission and emission systems. (In) TerPogossian, MM, Phelps, M.E., Brownell, G.L., eds. Reconstruction Tomography in Diagnostic Radiology and Nuclear Medicine. University Park Press, Baltimore, Md., 1977, pp. 139-154. , 152. Podolsky, S. and Burrows, B.A. Severity of potassium depletion in hyper-osmolar non-ketotic diabetic coma. Gerontologist 17:108, 1977 (Abstr.) 153. Podelsky, S. and Burrows, B.A.: Does long-term diuretic therapy of hyper-tension cause potassium depletion? Effects of "K-Losing" and "K-Sp2;ing" diuretic regimens on serum'and body potassium in essential hypertension. Prevent. Med. l.: 123, 1978 (Abstr.) 154. Podolsky, S. and Burrows, B.A.: Total body and serum potassium changes in "K-losing" and "K-sparing" antihypertensive regimens. Clin. Res. 26: 593A, 1978.(Abstr.) 155. Burrows, B.A., and Podolsky, S.: Does Long Term Diuretic Therapy of Hypertension cause Potassium Depletion? Effects of "K-Losing" and "K-Sparing" Diuretic Regimens on Serum and Body Potassium in Essential Hypertension. National Conf. on High Blood Pressure, Los Angeles, Calif. 4/2-4/4/78. 156. Podolsky, Stephen and Burrows, Belton A.: Total Body and Serum Potassium Changes in "K-Losing" and "K-Sparing" Antihypertensive regimens. Seventh Annual Meeting of the American College of Clinical Pharmacology, San Francisco, Calif. 4/27-5/2/78. 157. Burrows, B. A. , Podolsky~, S. , Cardarelli, _[. A. , Burney, S.W. , Morley, D.P. and Genna, S.: Body Potassium Changes 0lth Antihypertensive Diuretic Therapy. 25th Annual Meeting of the Society of Nuclear Medicine, Anaheim, Calif. 6/25-30/78. 158. Podolsky, S., and Burrows, B.A.: Comparison of "K-Sparing" and "K-Losing" Diuretic Regimens in Antihypertensive Therapy. XIth International Congress of Gerontology, Tokyo, Japan, 8/20-25/78. 159. Burrows, B.A., Podolsky, S., Cardarelli, J.A., Burney, S.W., Morley, D.P. and Genna, S.: Body potassium changes with antihypertensive diuretics. World Fed, of Nucl. Med. and Biology Meeting, Washington, D.C., Sept. 1978. 160. Burrows, B.A., Podolsky, S., Cardarelli, J.A., Burney, S.W., Morley, D.P. and Genna, S. Body potassium changes with antihypertensive diuretic therapy. J. of Nucl. Med. 19:721, 1978. v. j
i I Bibliography - B. A. Burrows M.D. i Page 13 161. Burrows, B. A. , Podolsky, S. , Cardarelli, J. A. , Bu'rney, S.W. , Morley, D.P. , j and :'enna, S. Body Potassium Changes with antihypertensive diuretics. l World Fed. of Nucl. Med. and Biology, 1978, pg. 137. 162. Podolsky, S., and Burrows, B.A. Effects of once daily diuretic therapy on Gerontologist 18: body K and serum K levels in essential hypertension. 112, 1978. 163. Slingerland, D. Ward, Burrows, Belton A. Long-term antithyroid treatment ' in hyperthyroidism. JAMA Vol. 242, No. 22, 2408-2410,1979. 164. Podolsky, Stephen and Burrows, Belton A. Potassium Depletion: A cause of impaired carbohydrate tolerance in hepatic cirrhosis and other disease states. In Secondary Diabetes: The Spectrum of the Diabetic Syndromes, , S. Podolsky and W. Viswanathan, eds, Raven Press, New York,1980, pp.437-448. 165. Burrows, B.A., Cardarelli, John C., Boling, Eldon A., and Sinex, F. Marott. ; The medical effects of radioactive fall-out: role of stable end-products? Trans. Am. Clin & Clim. Assoc. , 1981, 92:227-33. 166, Borkan, C.A., Hults, D.E., Cardarelli, J.A., Burrows, B.A. Comparison of Ultrasound and Skinfold measurements in assessment: of subcutaneous and " 3 total fatness. Am. J. Phys. Anthrop. 58:307-313, 1982. 167. Borkan, G.A., Hults, D.E., Gerzof, S.G., Burrows, B.A. and Robbins, A.H. Relationships between computed tomography tissue areas, thicknesses and total body composition. Ann. of Human Biology (in press). 168. Burrows, Belton A. , Cardarelli, John A., Sinex, F. Marott, Lefkin, Howard L. and Teager, Herbert M. The Variability in Fallout Radionuclides Distribution: Po tential Radiochemical Damage. Trans. Am. Clin & Clim Assoc, 94: 154-160, 1982. 169. Cardarelli, John A., Burrows, Belton A., Miller, Aaron, Slingerland, D. Uard l Correction of attenuation in whole-body determination of Co-57 L:_ absorp-u on . J. Nucl. Med. 24: 949-951, 1983. . 170. Slingerland, D. Ward, Cardarelli, John A., Burrows, Belton A. , Miller, Aaron l The utility of serum gast,rin levels in assessing the significance of low serum B12 levels. Arch. Int;Med. 1984;144:116721168. 171. Konstantin N Pavlou, William P Steff ee, Robert H Lerman and Belton A Burrows i Effects of dieting and exercise on lean body mass, oxygen uptake, and l strength. Med. and Sci. dn' Sports and Exercise Vol.17, No.4, Feb.1985, 172. Cardarelli, John A, Slingerland, D. Hard, Burrows, Belton A. and Miller, Aaron ; Measurement of Total-Body Cobalt-57 Vitamin B12 Absorption with a Gamma Camera. J. of Nucl.Med. Vol. 26, No. 8, Aug. 1985, 941-943. t. I J
. ,,- . Bibliography - B.'A.' Burrows, M.D.
Page 14-173 Miller, A., Slingerland, D.W., Burrows, B.A., Cardarelli, J.A. , The diagnostic evaluation of low serum vitamin B 12 Nuklearmedizin- 'l Supp.24:798, 1988. 174. Cardarelli, J.A., Slingerland, D.W., Miller, A.,_ Burrows B.A. Specially shielded gamma camera for measurement of B12 absorption. European Nuclear Medicine Congress, Milano,1988 ( Abstr.) 3 175 Miller, A., Slingerland, D.W., Cardarelli, J. and Burrows, B.A.
'Further studies on the use of serum gastrin levels in assessing the -
significance of low-serum B12 levels. Am. J. of Hematology, 1989 (In press) 176. Burrows, Belton A., Chalmers, Thomas C., and Cardarelli, John A. Global Fallout Distribution in Fireplace Ashes. Trans. Am. Clin & Clim. Assoc, 1989 (In press) i l
~
l I l 1 l I l 1 j
- t. l I
< ;l l
7te,g r N 4.K , June 26,198989 JtN 29 P4:051
. /j L. UNITED STATES OF AMERICA 'i I NUCLEAR REGULATORY COMMISSION [...Cb ! ^>l<' > l' ! ' .N L ?.R E -
p ATOMIC SAFETY AND LICENSING BOARD Before Administrative Judges: Ivan'W. Smith, Cheirman Richard F.-Cole .* Kenneth A. - McCollom
)- Docket No. 50-443-OL-1 >
In the Matter of ) ,i
) '(Off-site. Emergency PUBLIC SERVICE COMPANY OF ) Planning and Safety OF NEW HAMPSHIRE, et al. ) Issues) j ) i (Seabrook Station, Unit 1 -) i ) 1 CERTIFICATE OF SERVICE I hereby certify.that copies of the.within Testimony of Belton A. Burrows, MD, together with Dr. Burrows' Curriculum Vitae (on Behalf of the Seacost Ant 1-Pollution League), on Issues re:
MS-1 Hospitals, Reception / Decontamination Centers and FEMA (GM). j MS-1 Guidance have been forwarded this.26th day of June, 1989 by 2 . first-class mail, postage prepaid to all parties on the attached service list.
-l Respectfully submitt'd, e l Seacoast Anti-Pollution League ;
By its Attorneys, i l BACKUS, MEYER'& SOLOMON j By: ~ WA/// If6bert A. Backus, Esquire .j 116 Lowell~ Street i P.O. Box 516 : Kanchester, EH 03105 '! (603) 668-7272-u - . .
3 4.
.Ivan W. Smith, Chairman ~ -Suzanne Braiseth- Thomas Dignan Etquira ; Atomic ^ Safety and. ' Board of. Selectmen Ropes-& Gray . Licensing. Board Town Hall OnfIstEnational Place -US NRC One Drinkwat'er'Rond' Bost'ohYMA 02110-2624-Washington, DC. 20555 Hampton Falls, NH 03844 5 JLN 29 ' P4 :05 - - 0FFid - .. ;A '
Ktnneth A. McCollom Docketing & Service Sec. 00CMfgudht[I iAtomic Safety and~ Office of.the Secretary SAPL". Licensing Board US NRC 5 Market Street-US NRC- Washington, DC 20555- Portsmouth, NH 03801 ' Washington, DC 20555 Office of Selectmen Richard F. Cole' Geoffrey Huntington, Esquire Town of Hampton Falls. Atomic Safety and Licensing Attorney General's. Office. Hampton Falls, NH 03844 Board State House Annex U3 NRC . Concord, NH 03301 q Washington,'DC 20555 j j Ashod N. Amirian, Esquire Joseph Flynn, Asst. Gen. Cus1. Sandra Gavutis-145 South hin Street Federal Emergency Town of Kensington P.O. Box 38 Management Agency Box.1154 i Bradford, MA 01835 500 C Street SW . East Kensington, NH 03827 [ Washington, DC 20555 1 John Traficonte Esquire Sherwin E. Turk, Esquire Charles P. Graham,' Esquire Assistant Attorney General Office of Exec. Legal Dr. McKay, Murphy and Graham One Ashburton Place US NRC
' ~
100 Main Street 19th Floor Washington, DC 20555 Amesbury,'MA 01913 Boston, MA 02108 R. Scott Hill-Whilton, Esq. Judith H. Mizner Esquire William S. Lord . 79 State Street 79 State Street "ewburyport, MA 01950 Office of Selectmen. l Newburyport, MA 01950 Town Hall. i ' Friend Street l Amesbury, MA 01913 l l ? l
~ Diane Curran, Esquire Paul McEachern, Esquire . Senator Gordon J." Humphrey - -
Harmon, Curran & Tousley Shaines & McEachern 20001 S Street NW US. Senate .. 25 Maplewood Avenuea . Washington, DC4 20510 Suite 430 l
~ -P.O.-Box.360 Atta:s Janet'Coitt !
Washington, DC. 20009 Portsmouth, NH: 03801 l
-w v.
m,, - ,w . . - 9.; n % ~ ti l M a.
- r: x Q
. $,.,$m$.s . n. ll,l l, , LA 1.'. ui - c."L &- O NL- #15 ## - ' ";
- 9 J. P. Nadssu-Town of Rye 'i 155 Washington Road.
Rye, NH 03870 1 Adjudicatory File ; Atomic Safety and Licensing Board Panel US NRC Washington, DC 20555 Richard R. Donovan FEMA. Faderal Registry Center 130 228th Street, SW .j Bothell, WA 98021-9796 Robert R. Pierce, Esquire Atomic' Safety and Licensing Panel US NRC j Washington, DC 20555 - I
] i 4
0 i 5 i
)
_};. _
'= ..h t.__' :-:f 6 ~ . r .- ',\- . , s , c. . . , ,-, . i ;L.
4 <
. r- ,
p ,, J
#'pl '#
g ';L '4 < . ' - 9 ,' '4' . #i : y 5 1 g , , fE 's . _4 ff .
~ , ,r N' .r. ' ' i Y ' ,' t . . . $Ym.~ ,
h * ' ' *W .+ ,i
. ^ s, v sw. :e , w rme ~:msw tema . . :a > - .,}}